Sierra Summit Advisors’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
SW
Sierra Summit Advisors's ASTH Position: Q4 2024 in Review
Sierra Summit Advisors sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 14,787 shares — an estimated $857K sold.
Sierra Summit Advisors first reported a position in ASTH in Q3 2024 and held it in 1 quarter. The position peaked at $857K in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.
- Sierra Summit Advisors reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
- Sierra Summit Advisors sold 14,787 Astrana Health shares in Q4 2024, an estimated $857K.
- Sierra Summit Advisors first reported a position in Astrana Health in Q3 2024 and held it in 1 quarter.
- Sierra Summit Advisors's Astrana Health position peaked at $857K in Q3 2024.
- 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.
Based on Sierra Summit Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.